By contrast, with the melanoma cells in h-CLATw/M, RD was shown to upregulate the expression of CD86 and IL-12 much more than it did in h-CLAT, suggesting that RD is a tyrosinase- and melanocyte-specific sensitizer. Here, CD86 is linked to melanoma.